Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Kauliv, teriparatide, Osteoporosis;Osteoporosis, Postmenopausal, Date of authorisation: 12/01/2023, Revision: 1, Status: Authorised
TO: